7 studies found for:    15681523 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Angiogenesis Inhibitors and Hypertension: Clinical Aspects
Condition: Hypertension
Intervention:
2 Terminated
Has Results
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Condition: Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Docetaxel;   Drug: CPT-11;   Drug: Paclitaxel;   Drug: Vinorelbine Tartrate;   Drug: Gemcitabine
3 Completed Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
Condition: Breast Cancer
Interventions: Behavioral: Exercise Training;   Behavioral: Chemo only
4 Completed A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab, Docetaxel;   Drug: Trastuzumab, Docetaxel, Bevacizumab;   Drug: Trastuzumab+Docetaxel+NPLD;   Drug: Trastuzumab+Docetaxel+NPLD+Bevacizumab
5 Completed Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
6 Withdrawn A Study of Bevacizumab to Prevent Malignant Ascites
Condition: Malignant Ascites
Intervention: Drug: Bevacizumab
7 Recruiting Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
Conditions: Metastatic Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Intervention: Drug: Bevacizumab and eribulin

Indicates status has not been verified in more than two years